Home » Topics » Regulatory

Regulatory
RSS

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Xalatan approved for U.S. market

June 14, 1996

Actimmune metastatic renal cell carcinoma development terminated

June 14, 1996

Augmentin's new dosing/formulation cleared by FDA

June 14, 1996

Single-dose hepatitis A vaccine available

June 7, 1996

Tranilast: An angiotensin II antagonist

June 7, 1996

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Transdermal buspirone covered under U.S. patent

June 7, 1996

InSite Vision and Ciba Vision marketing agreement for sustained-release eyedrop formulation

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...